Research Stream: Psychiatric Genomics
Schizophrenia is a complex disorder with a strong genetic component.
Led by Professor Bryan Mowry, the Queensland Centre for Mental Health Research's Psychiatric Genomics Group focuses on identifying risk genes for schizophrenia, and profiling the roles of these genes using neuroimaging, animal and human stem cell models.
As well as our work conducted within the laboratory, we have also contributed to large consortia at both the national (Australian Schizophrenia Research Bank) and international (Psychiatric Genomic Consortium) levels. These collaborations have resulted in huge strides in our understanding of the complex genetics behind this complex disorder.
Our work in identifying risk genes and understanding the role they play in schizophrenia development and progression will be vital in providing better targeted therapies for this debilitating disorder in the future.
Visit the Mowry Group page on the University of Queensland's website.
The primary research goal is to identify and functionally characterise susceptibility genes for schizophrenia and related disorders. A special focus is on the study of large collaborative samples and ethnically homogeneous populations.
The group aims to achieve this by using genome-wide association studies (GWAS), DNA and RNA sequencing, and gene expression studies.